摘要
目的 :研制功能性抗CD4 0L单克隆抗体 ,探讨其生物学特性及其运用价值。方法 :采用B淋巴细胞融合、免疫荧光、免疫印迹和竞争抑制等方法获得鼠抗人CD4 0LmAb ,通过Daudi细胞生长抑制试验、混合淋巴细胞反应观察抗CD4 0LmAb的生物学功能。结果 :经表型分析、Westernblot和竞争抑制试验 ,证实mAbB1、mAb4F1是识别人CD4 0L分子的特异性单抗 ,且识别的位点不同 ;mAbB1、mAb4F1均能不同程度地拮抗CD4 0L TC介导的Daudi细胞生长抑制和抑制混合淋巴细胞反应。结论 :成功地获得两株能稳定分泌特异性抗人CD4 0L单克隆抗体的杂交瘤 (1B1、4F1) ,这两株单抗对CD4 0L的生物学功能具有明显的阻断作用 。
Objective:To prepare mouse anti human CD40L antigen monoclonal antibody and study its biological characteristics and functions.Methods:Using CD40L transfected cell as antigen,cell fusion,mAb screening,immunofluorescence,Western blot and competitive test,obtain two mouse anti human CD40 mAb.Their biological functions are evaluated by the analysis of the effect of the Daudi cell proliferation and the mixed lymphocyte reaction.Results:On the basis of phenotype analysis and competition test,it was evidenced that 1B1 and 4F1 recognized different epitopes of human CD40L antigen specially,and they could reverse the growth inhibition of Daudi cell mediated by CD40L transfected cells and reduce MLR in different extents.Conclusion:Two stable hybridomas murine anti human CD40L monoclonal antibodies have been obtained and antibodies(1B1?4F1)showed a obviously blocking function for CD40/CD40L signal.
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2002年第6期388-391,共4页
Chinese Journal of Immunology
基金
国家自然科学杰出青年基金 (3 962 5 0 2 4)
国家自然科学基金(3 9870 82 5 )